Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

32 та иш

Иш: Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study

  1. The 2011 update of the World Health Organization guidelines for the programmatic management of drug-resistant tuberculosis

    Dennis Falzon, Ernesto Jaramillo, Holger J. Schünemann

    Мақола20115 иқтибос
    ABI

  2. Reasons for defaulting from drug-resistant tuberculosis treatment in Armenia: a quantitative and qualitative study

    Elisabeth Sánchez-Padilla, Caroline Marquer, Stobdan Kalon +5

    Мақола20145 иқтибос
    ABI

  3. Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes

    Dennis Falzon, Neel R. Gandhi, Giovanni Battista Migliori +11

    Шарҳ мақола20124 иқтибос
    ABI

  4. Treatment of Tuberculosis in a Region with High Drug Resistance: Outcomes, Drug Resistance Amplification and Re-Infection

    Maryline Bonnet, Manuela Pardini, Francesca Meacci +14

    Мақола20114 иқтибос
    ABI

  5. Treatment Outcomes of Patients With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis According to Drug Susceptibility Testing to First- and Second-line Drugs: An Individual Patient Data Meta-analysis

    Mayara Lisboa Bastos, Hamidah Hussain, Karin Weyer +82

    Шарҳ мақола20144 иқтибос
    ABI

  6. Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects

    Ekaterina V. Kurbatova, A. Taylor, Victoria M. Gammino +13

    Мақола20123 иқтибос
    ABI

  7. Comparison of Treatment Outcomes of New Smear-Positive Pulmonary Tuberculosis Patients by HIV and Antiretroviral Status in a TB/HIV Clinic, Malawi

    Hannock Tweya, Caryl Feldacker, Sam Phiri +9

    Мақола20132 иқтибос
    ABI

  8. Treatment Outcomes of Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis

    James C. Johnston, Neal Shahidi, Mohsen Sadatsafavi +1

    Шарҳ мақола20092 иқтибос
    ABI

  9. High Prevalence of Multidrug-Resistant Tuberculosis, Swaziland, 2009–2010

    Elisabeth Sánchez-Padilla, Themba Dlamini, Alexandra Ascorra +7

    Мақола20122 иқтибос
    ABI

  10. Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis

    Vija Skripconoka, Manfred Danilovitš, Lea Pehme +10

    Мақола20122 иқтибос
    ABI

  11. Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug Resistance

    Andreas H. Diacon, Peter R. Donald, Alexander S. Pym +11

    Мақола20122 иқтибос
    ABI

  12. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  13. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  14. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  15. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  16. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  17. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  18. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  19. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  20. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  21. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  22. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  23. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  24. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  25. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI